Literature DB >> 8994061

Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice.

P H Tu1, K A Robinson, F de Snoo, J Eyer, A Peterson, V M Lee, J Q Trojanowski.   

Abstract

Transgenic (NFHLacZ) mice expressing a fusion protein composed of a truncated high-molecular-weight mouse neurofilament (NF) protein (NFH) fused to beta-galactosidase (LacZ) develop inclusions in neurons throughout the CNS. These inclusions persist from birth to advanced age and contain massive filamentous aggregates including all three endogenous NF proteins and the NFHLacZ fusion protein. Further, the levels of endogenous NF proteins are selectively reduced in NFHLacZ mice. Because these inclusions resemble NF-rich Lewy bodies (LBs) in Parkinson's disease and LB dementia, we asked whether these lesions compromised the viability of affected neurons during aging. We studied hippocampal CA1 neurons, nearly all of which harbored inclusions (type I) devoid of cellular organelles, and cerebellar Purkinje cells, nearly all of which accumulated inclusions (type II) containing numerous entrapped organelles. Purkinje cells with type II inclusions began to degenerate in the NFHLacZ mice at approximately 1 year of age, and most were eliminated by 18 months of age. In contrast, there was no significant loss of type I inclusion-bearing CA1 neurons with age. These data suggest that the sequestration of cellular organelles in type II inclusions may isolate and impair the function of these organelles, thereby rendering Purkinje cells selectively vulnerable to degeneration with age as in neurodegenerative diseases of the elderly characterized by accumulation of LBs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994061      PMCID: PMC6573175     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

1.  Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.

Authors:  S E Arnold; V M Lee; R E Gur; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 2.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

3.  Greater number of microtubules per axon of unmyelinated fibers of mutant quails deficient in neurofilaments: possible compensation for the absence of neurofilaments.

Authors:  J X Zhao; A Ohnishi; C Itakura; M Mizutani; T Yamamoto; H Hayashi; Y Murai
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated neurofilament epitope.

Authors:  Y Nakazato; J Hirato; Y Ishida; S Hoshi; M Hasegawa; T Fukuda
Journal:  J Neuropathol Exp Neurol       Date:  1990-05       Impact factor: 3.685

Review 5.  On the assembly mechanism of neurofilaments.

Authors:  S Tokutake
Journal:  Int J Biochem       Date:  1990

6.  Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules.

Authors:  S Hisanaga; M Kusubata; E Okumura; T Kishimoto
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

7.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

8.  Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene.

Authors:  O Ohara; Y Gahara; T Miyake; H Teraoka; T Kitamura
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

9.  Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits.

Authors:  P H Tu; G Elder; R A Lazzarini; D Nelson; J Q Trojanowski; V M Lee
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  Neurofilaments are obligate heteropolymers in vivo.

Authors:  M K Lee; Z Xu; P C Wong; D W Cleveland
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  12 in total

Review 1.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

2.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Nicholas H McGarvey; Nicola J Rutherford; Carolina Ceballos-Diaz; Janice Robertson; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2014-05       Impact factor: 17.088

3.  Neurofilaments bind tubulin and modulate its polymerization.

Authors:  Arnaud Bocquet; Raphael Berges; Ronald Frank; Patrick Robert; Alan C Peterson; Joël Eyer
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

4.  Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice.

Authors:  G Y Ching; C L Chien; R Flores; R K Liem
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

5.  Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit.

Authors:  J M Beaulieu; H Jacomy; J P Julien
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

Review 6.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

7.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 8.  Protein accumulation in traumatic brain injury.

Authors:  Douglas H Smith; Kunihiro Uryu; Kathryn E Saatman; John Q Trojanowski; Tracy K McIntosh
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

9.  Postmortem studies in Parkinson's disease.

Authors:  Andreas Hartmann
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

10.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.